June 22, 2012 — The University of Miami Miller School of Medicine’s Interdisciplinary Stem Cell Institute (ISCI) announced that it received a $10 million grant from The Starr Foundation, one of the largest private foundations in the United States.

June 22, 2012 –– The U.S. Food and Drug Administration (FDA) recently selected a stent graft being developed by Medtronic Inc. for an early feasibility pilot program that allows for “early clinical evaluation to provide proof of principle and initial clinical safety data.”

June 22, 2012 — Bayer HealthCare widens its portfolio of interventional solutions by introducing the Jetstream Navitus L Atherectomy Catheter. Positioned as the largest diameter rotational atherectomy device in the Jetstream catheter family, the Navitus L catheter can create a lumen 30 percent larger than the standard Navitus device. 

 

June 22, 2012 — Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic injectors.


June 22, 2012 — The the U.S. Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee voted in May against recommending approval of expanding the indication for rivaroxaban (Xarelto) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).


 

June 21, 2012 — A class action suit has been filed against St. Jude Medical Inc. on behalf of purchasers of the company's defibrillator leads. The Riata and Riata ST electrical wire leads were observed to wear through the silicone casing meant to contain them, going on to protrude into the body.

 
Subscribe Now